Adage Capital Partners Gp, L.L.C. Ptc Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 595,000 shares of PTCT stock, worth $29.3 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
595,000
Previous 306,756
93.97%
Holding current value
$29.3 Million
Previous $13.8 Million
118.99%
% of portfolio
0.06%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding PTCT
# of Institutions
287Shares Held
78.8MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$424 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$383 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$369 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$268 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$267 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.53B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...